SCHEMBL9364303

SCHEMBL9364303

CCCOC(=O)OC1=C(C)N(C)C(C)=C(OC(=O)OCCC)C1c1ccc(C#N)cc1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM4E B2RXH2 2/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
ELANE P08246 4/20 0.36
CYP3A4 P08684 2/20 0.36
CYP2C9 P11712 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HRH2 P25021 1/20 0.36
HRH1 P35367 1/20 0.36
HRH3 Q9Y5N1 1/20 0.36
ACHE P22303 1/20 0.36
MGLL Q99685 2/20 0.35
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
KDM1A O60341 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9364315 0.84 NPSR1 (0.42) HPGDNPSR1SMN1; SMN2KDM4EGAA
SCHEMBL9220779 0.83 ADRA2A (0.35) HPGDNPSR1SMN1; SMN2KDM4EGAA
SCHEMBL9120794 0.82 NPSR1 (0.57) HPGDNPSR1SMN1; SMN2KDM4EGAA
SCHEMBL9367574 0.80 GAA (0.39) HPGDKDM4EGAAHTTCYP3A4
SCHEMBL9364015 0.78 HSP90AA1 (0.42) HPGDNPSR1SMN1; SMN2KDM4EGAA
SCHEMBL9364030 0.78 HPGD (0.43) HPGDNPSR1SMN1; SMN2KDM4EGAA
SCHEMBL9363815 0.75 NPSR1 (0.48) HPGDNPSR1SMN1; SMN2KDM4EGAA
SCHEMBL9364552 0.75 ALDH1A1 (0.40) HPGDNPSR1SMN1; SMN2KDM4EGAA
SCHEMBL9368993 0.74 ADORA3 (0.45) SMN1; SMN2L3MBTL1HRH2HRH1MGLL
SCHEMBL9364528 0.72 NPSR1 (0.45) HPGDNPSR1SMN1; SMN2KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0451654-A2 Use of N-alkylated 1,4-dihydropyridine carboxylic acid esters as drugs, new compounds and process for their preparation BAYER AG (DE) 1991-10-16 EP claimed
EP-0451654-B1 Use of N-alkylated 1,4-dihydropyridine carboxylic acid esters as drugs, new compounds and process for their preparation BAYER AG (DE) 1994-09-07 EP disclosed
EP-0451654-A2 Use of N-alkylated 1,4-dihydropyridine carboxylic acid esters as drugs, new compounds and process for their preparation BAYER AG (DE) 1991-10-16 EP disclosed